An evidence-based review of skin cancer rates on biologic therapies.
about
Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses.Systemic therapies for psoriasis: an evidence-based update.Skin cancer in patients with psoriasis.Cohort study of malignancies and hospitalized infectious events in treated and untreated patients with psoriasis and a general population in the United States.Checkpoint Blockade Toxicity and Immune Homeostasis in the Gastrointestinal Tract.
P2860
An evidence-based review of skin cancer rates on biologic therapies.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
An evidence-based review of skin cancer rates on biologic therapies.
@ast
An evidence-based review of skin cancer rates on biologic therapies.
@en
An evidence-based review of skin cancer rates on biologic therapies.
@nl
type
label
An evidence-based review of skin cancer rates on biologic therapies.
@ast
An evidence-based review of skin cancer rates on biologic therapies.
@en
An evidence-based review of skin cancer rates on biologic therapies.
@nl
prefLabel
An evidence-based review of skin cancer rates on biologic therapies.
@ast
An evidence-based review of skin cancer rates on biologic therapies.
@en
An evidence-based review of skin cancer rates on biologic therapies.
@nl
P2093
P2860
P1476
An evidence-based review of skin cancer rates on biologic therapies.
@en
P2093
Faranak Kamangar
Isaac M Neuhaus
John Y M Koo
P2860
P304
P356
10.3109/09546634.2011.652064
P577
2012-08-01T00:00:00Z